LPL Financial’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-11,696
| Closed | -$20K | – | 3034 |
|
2017
Q1 | $20K | Sell |
11,696
-27,430
| -70% | -$46.9K | ﹤0.01% | 2681 |
|
2016
Q4 | $213K | Sell |
39,126
-1,477
| -4% | -$8.04K | ﹤0.01% | 2441 |
|
2016
Q3 | $223K | Sell |
40,603
-2,507
| -6% | -$13.8K | ﹤0.01% | 2336 |
|
2016
Q2 | $247K | Sell |
43,110
-45,458
| -51% | -$260K | ﹤0.01% | 2230 |
|
2016
Q1 | $429K | Sell |
88,568
-1,700
| -2% | -$8.23K | ﹤0.01% | 2256 |
|
2015
Q4 | $538K | Buy |
90,268
+43,211
| +92% | +$258K | ﹤0.01% | 2141 |
|
2015
Q3 | $328K | Buy |
47,057
+110
| +0.2% | +$767 | ﹤0.01% | 2135 |
|
2015
Q2 | $298K | Sell |
46,947
-750
| -2% | -$4.76K | ﹤0.01% | 2308 |
|
2015
Q1 | $386K | Sell |
47,697
-550
| -1% | -$4.45K | ﹤0.01% | 2042 |
|
2014
Q4 | $244K | Sell |
48,247
-3,021
| -6% | -$15.3K | ﹤0.01% | 2341 |
|
2014
Q3 | $247K | Sell |
51,268
-1,091
| -2% | -$5.26K | ﹤0.01% | 2313 |
|
2014
Q2 | $407K | Buy |
52,359
+840
| +2% | +$6.53K | ﹤0.01% | 1961 |
|
2014
Q1 | $360K | Sell |
51,519
-3,685
| -7% | -$25.8K | ﹤0.01% | 2011 |
|
2013
Q4 | $331K | Sell |
55,204
-11,982
| -18% | -$71.8K | ﹤0.01% | 2045 |
|
2013
Q3 | $427K | Hold |
67,186
| – | – | ﹤0.01% | 1759 |
|
2013
Q2 | $255K | Buy |
+67,186
| New | +$255K | ﹤0.01% | 2019 |
|